Total Payments
$13,381
2024 Payments
$1,501
Companies
39
Transactions
292
Medicare Patients
8,175
Medicare Billing
$783,577
Payment Breakdown by Category
Food & Beverage$9,308 (69.6%)
Travel$3,933 (29.4%)
Education$140.17 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,308 | 281 | 69.6% |
| Travel and Lodging | $3,933 | 7 | 29.4% |
| Education | $140.17 | 4 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $5,125 | 32 | $0 (2024) |
| Alphatec Spine, Inc | $1,821 | 3 | $0 (2022) |
| ABIOMED | $765.86 | 11 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $650.26 | 33 | $0 (2024) |
| Amgen Inc. | $597.96 | 37 | $0 (2024) |
| BIOTRONIK INC. | $519.41 | 10 | $0 (2021) |
| Boston Scientific Corporation | $387.00 | 12 | $0 (2024) |
| Medtronic Vascular, Inc. | $291.83 | 7 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $273.00 | 18 | $0 (2024) |
| BARD PERIPHERAL VASCULAR, INC. | $256.01 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,501 | 51 | Abbott Laboratories ($161.45) |
| 2023 | $3,779 | 63 | Abbott Laboratories ($2,797) |
| 2022 | $2,317 | 25 | Alphatec Spine, Inc ($1,680) |
| 2021 | $455.07 | 11 | ABIOMED ($114.72) |
| 2020 | $676.39 | 15 | Abbott Laboratories ($375.95) |
| 2019 | $1,345 | 48 | Abbott Laboratories ($362.57) |
| 2018 | $1,958 | 35 | Abbott Laboratories ($907.32) |
| 2017 | $1,349 | 44 | Abbott Laboratories ($329.00) |
All Payment Transactions
292 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 12/06/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $148.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/04/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.39 | General |
| 10/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Cardiology | ||||||
| 10/22/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $29.94 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 10/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $142.68 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/18/2024 | DePuy Synthes Sales Inc. | Teligen (Device) | Food and Beverage | In-kind items and services | $40.34 | General |
| Category: Spine | ||||||
| 09/12/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/06/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 09/05/2024 | W. L. Gore & Associates, Inc. | GORE CARDIOFORM Septal Occluder (Device) | Food and Beverage | In-kind items and services | $142.09 | General |
| Category: Devices | ||||||
| 08/26/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.78 | General |
| 08/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/13/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.59 | General |
| 08/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/30/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.50 | General |
| 07/29/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.25 | General |
| Category: Cardiovascular | ||||||
| 07/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,854 | 2,816 | $659,045 | $184,479 |
| 2022 | 27 | 2,258 | 3,360 | $936,367 | $201,940 |
| 2021 | 28 | 2,039 | 3,146 | $874,374 | $204,695 |
| 2020 | 22 | 2,024 | 2,991 | $872,971 | $192,464 |
Total Patients
8,175
Total Services
12,313
Medicare Billing
$783,577
Procedure Codes
108
All Medicare Procedures & Services
108 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 371 | 721 | $104,545 | $67,040 | 64.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 266 | 522 | $195,750 | $33,687 | 17.2% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 24 | 24 | $21,600 | $16,566 | 76.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 107 | 109 | $20,710 | $11,691 | 56.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 375 | 659 | $52,720 | $7,108 | 13.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 49 | 49 | $48,570 | $6,920 | 14.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 116 | 117 | $38,610 | $6,478 | 16.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 40 | 41 | $10,250 | $5,856 | 57.1% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 66 | 66 | $26,400 | $3,520 | 13.3% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 17 | 17 | $65,552 | $3,375 | 5.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 18 | 19 | $9,500 | $3,199 | 33.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $7,200 | $3,021 | 42.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 25 | 29 | $12,325 | $2,842 | 23.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 23 | $4,140 | $2,768 | 66.9% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 25 | 25 | $4,500 | $2,451 | 54.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 14 | 14 | $5,460 | $2,054 | 37.6% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 46 | 50 | $7,500 | $1,507 | 20.1% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 46 | 50 | $7,000 | $1,051 | 15.0% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 43 | 43 | $3,440 | $897.84 | 26.1% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 22 | 25 | $3,125 | $612.00 | 19.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 26 | 33 | $2,673 | $602.21 | 22.5% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 22 | 25 | $3,125 | $461.75 | 14.8% |
| 85610 | Blood test, clotting time | Office | 2023 | 39 | 74 | $1,110 | $310.80 | 28.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 24 | 24 | $1,920 | $249.12 | 13.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 26 | 33 | $1,320 | $213.45 | 16.2% |
About Dr. Mohammed Khan, MD
Dr. Mohammed Khan, MD is a Cardiovascular Disease healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932170149.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammed Khan, MD has received a total of $13,381 in payments from pharmaceutical and medical device companies, with $1,501 received in 2024. These payments were reported across 292 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($9,308).
As a Medicare-enrolled provider, Khan has provided services to 8,175 Medicare beneficiaries, totaling 12,313 services with total Medicare billing of $783,577. Data is available for 4 years (2020–2023), covering 108 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Houston, TX
- Active Since 01/27/2006
- Last Updated 05/08/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1932170149
Products in Payments
- XIENCE XPEDITION (Device) $2,113
- Other - Miscellaneous (Device) $1,680
- Impella (Device) $697.09
- XARELTO (Drug) $650.26
- Confirm Rx (Device) $387.87
- Merlin Connectivity and Remote (Device) $354.01
- Quartet CRT Lead (Device) $350.65
- XIENCE SKYPOINT (Device) $346.67
- Repatha (Biological) $342.87
- Ablation Therapy Hardware (Device) $329.00
- AVEIR (Device) $314.12
- CRT-Ds (Device) $290.31
- VERQUVO (Drug) $242.03
- Corlanor (Drug) $213.64
- WATCHMAN FLX (Device) $183.11
- ELIQUIS (Drug) $172.53
- Quadra Allure MP RF CRT Pacemkr (Device) $170.00
- CONFIRM RX (Device) $167.25
- BRILINTA (Drug) $148.94
- GORE CARDIOFORM Septal Occluder (Device) $142.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Houston
Reynolds Delgado, M.d, M.D
Cardiovascular Disease — Payments: $600,466
Cardiovascular Disease $600,466
Dr. Miguel Valderrabano, Md, MD
Cardiovascular Disease — Payments: $471,736
Cardiovascular Disease $471,736
Asif Ali, Md, MD
Cardiovascular Disease — Payments: $461,190
Cardiovascular Disease $461,190
Mr. Mehdi Razavi, Md, MD
Cardiovascular Disease — Payments: $433,792
Cardiovascular Disease $433,792
Dr. Michele Sartori, M.d, M.D
Cardiovascular Disease — Payments: $278,682
Cardiovascular Disease $278,682
Barry Trachtenberg, Md, MD
Cardiovascular Disease — Payments: $273,547
Cardiovascular Disease $273,547